These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 11523680

  • 1. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
    Parsa AT, Chi JH, Hurley PT, Jeyapalan SA, Bruce JN.
    Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
    [Abstract] [Full Text] [Related]

  • 2. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
    Iwadate Y, Namba H, Tagawa M, Takenaga K, Sueyoshi K, Sakiyama S.
    Oncology; 1997 Sep; 54(4):329-34. PubMed ID: 9216859
    [Abstract] [Full Text] [Related]

  • 3. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
    Cool V, Pirotte B, Gérard C, Dargent JL, Baudson N, Levivier M, Goldman S, Hildebrand J, Brotchi J, Velu T.
    Hum Gene Ther; 1996 Mar 20; 7(5):627-35. PubMed ID: 8845388
    [Abstract] [Full Text] [Related]

  • 4. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
    Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO.
    Cancer Gene Ther; 1996 Mar 20; 3(2):99-106. PubMed ID: 8729908
    [Abstract] [Full Text] [Related]

  • 5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 20; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 6. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep 20; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 7. Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.
    Mori K, Iwata J, Miyazaki M, Osada H, Tange Y, Yamamoto T, Aiko Y, Tamura M, Shiroishi T.
    Neurol Med Chir (Tokyo); 2010 Sep 20; 50(7):545-53. PubMed ID: 20671379
    [Abstract] [Full Text] [Related]

  • 8. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D, Hardin J, Ray J, Gage FH.
    J Neurosurg; 1993 Nov 20; 79(5):729-35. PubMed ID: 8410252
    [Abstract] [Full Text] [Related]

  • 9. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
    Kruse CA, Roper MD, Kleinschmidt-DeMasters BK, Banuelos SJ, Smiley WR, Robbins JM, Burrows FJ.
    Cancer Gene Ther; 1997 Nov 20; 4(2):118-28. PubMed ID: 9080121
    [Abstract] [Full Text] [Related]

  • 10. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H, Tagawa M, Iwadate Y, Kimura M, Sueyoshi K, Sakiyama S.
    Hum Gene Ther; 1998 Jan 01; 9(1):5-11. PubMed ID: 9458237
    [Abstract] [Full Text] [Related]

  • 11. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors.
    Vincent AJ, Vogels R, Someren GV, Esandi MC, Noteboom JL, Avezaat CJ, Vecht C, Bekkum DW, Valerio D, Bout A, Hoogerbrugge PM.
    Hum Gene Ther; 1996 Jan 20; 7(2):197-205. PubMed ID: 8788170
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ, Trask TW, Chen SH, Goodman JC, Woo SL, Grossman RG, Shine HD.
    J Neurosci Res; 1994 Nov 01; 39(4):506-11. PubMed ID: 7884826
    [Abstract] [Full Text] [Related]

  • 13. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
    Jacobs AH, Winkeler A, Hartung M, Slack M, Dittmar C, Kummer C, Knoess C, Galldiks N, Vollmar S, Wienhard K, Heiss WD.
    Hum Gene Ther; 2003 Feb 10; 14(3):277-97. PubMed ID: 12639307
    [Abstract] [Full Text] [Related]

  • 14. Purified herpes simplex thymidine kinase retroviral particles. II. Influence of clinical parameters and bystander killing mechanisms.
    Kruse CA, Lamb C, Hogan S, Smiley WR, Kleinschmidt-Demasters BK, Burrows FJ.
    Cancer Gene Ther; 2000 Jan 10; 7(1):118-27. PubMed ID: 10678364
    [Abstract] [Full Text] [Related]

  • 15. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
    Rainov NG, Fels C, Droege JW, Schäfer C, Kramm CM, Chou TC.
    Cancer Gene Ther; 2001 Sep 10; 8(9):662-8. PubMed ID: 11593335
    [Abstract] [Full Text] [Related]

  • 16. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
    Tang Q, Zhang D, Wan M, Jin L.
    Cancer Biother Radiopharm; 2007 Dec 10; 22(6):755-61. PubMed ID: 18158766
    [Abstract] [Full Text] [Related]

  • 17. Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy.
    Estin D, Li M, Spray D, Wu JK.
    Neurosurgery; 1999 Feb 10; 44(2):361-8; discussion 368-9. PubMed ID: 9932890
    [Abstract] [Full Text] [Related]

  • 18. Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.
    Paul DB, Read SB, Kulprathipanja NV, Gomez GG, Kleinschmidt-DeMasters BK, Schiltz PM, Kruse CA.
    J Neurooncol; 2003 Feb 10; 64(1-2):89-99. PubMed ID: 12952290
    [Abstract] [Full Text] [Related]

  • 19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 15; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.